•Found
over- or under-expression of certain microRNA in dendritic cells affects their
ability to direct immune response
•Once
modified, these dendritic cells could be used in cellular therapy to treat a
wide range of immune conditions and diseases
•For
example, this cellular therapy technology has the potential to replace
long-term pharmaceutical immunosuppression therapy, be utilized as a more
benign cancer immunotherapy, and has potential as a
immunotherapeutic adjuvant